1 |
Show member pathways
|
13.45 |
TP53 RAF1 MYC KRAS HRAS EGFR |
2 |
Show member pathways
ErbB Family Pathway
63
ErbB2-ErbB3 Heterodimers
63
ErbB4 Pathway
63
Growth Hormone Signaling
63
HMGB1 Pathway
63
IL-4 Pathway
63
LPS Stimulated MAPK Signaling
63
PACAP Signaling
63
PI3K Signaling in B-Lymphocyte
63
Prolactin Signaling
63
Thrombopoietin Pathway
63
TREM1 Pathway
63
UVC-Induced MAPK Signaling
63
|
13.31 |
TP53 RAF1 MYC KRAS HRAS EGFR |
3 |
Show member pathways
|
13.16 |
TP53 RAF1 KRAS HRAS EGFR AKT1 |
4 |
Show member pathways
|
13.16 |
TP53 RAF1 MYC KRAS HRAS EGFR |
5 |
Show member pathways
CRHR Pathway
63
GHRH Signaling
63
Hedgehog Signaling in Mammals
63
Relaxin Pathway
63
Signaling in Gap Junctions
63
|
13.13 |
RAF1 KRAS HRAS EGFR CDKN2A AKT1 |
6 |
Show member pathways
|
13.09 |
TP53 RAF1 MYC KRAS HRAS EGFR |
7 |
Show member pathways
|
13.01 |
TP53 RAF1 MYC KRAS HRAS EGFR |
8 |
Show member pathways
Signal transduction PTEN pathway
22
|
12.95 |
TP53 RAF1 MYC KRAS HRAS EGFR |
9 |
Show member pathways
Cell adhesion Integrin inside-out signaling
22
Development ACM2 and ACM4 activation of ERK
22
Development Angiotensin signaling via PYK2
22
Development EDNRB signaling
22
Development EPO-induced MAPK pathway
22
Development G-Proteins mediated regulation MARK-ERK signaling
22
Signal transduction IP3 signaling
22
|
12.93 |
RAF1 KRAS HRAS EGFR AKT1 |
10 |
|
12.9 |
TP53 RAF1 MYC KRAS HRAS EGFR |
11 |
Show member pathways
Development Thrombopoietin-regulated cell processes
22
IL-9 Pathway
63
Immune response IL-9 signaling pathway
22
|
12.87 |
RAF1 MYC KRAS HRAS AKT1 |
12 |
|
12.86 |
TP53 RAF1 MYC KRAS HRAS EGFR |
13 |
Show member pathways
|
12.83 |
RAF1 KRAS HRAS EGFR AKT1 |
14 |
Show member pathways
|
12.82 |
TP53 KRAS HRAS EGFR AKT1 |
15 |
Show member pathways
Apoptosis and survival Anti-apoptotic action of membrane-bound ESR1
22
Apoptosis and survival NGF signaling pathway
22
Apoptosis and survival Role of CDK5 in neuronal death and survival
22
Development Neurotrophin family signaling
22
|
12.81 |
TP53 RAF1 KRAS HRAS AKT1 |
16 |
Show member pathways
Apoptosis and survival Apoptotic TNF-family pathways
22
|
12.8 |
TP53 RAF1 MYC KRAS HRAS CDKN2A |
17 |
Show member pathways
|
12.78 |
TP53 RAF1 MYC KRAS HRAS EGFR |
18 |
Show member pathways
|
12.77 |
RAF1 KRAS HRAS EGFR AKT1 |
19 |
Show member pathways
G-AlphaI Signaling
63
Thrombin Signaling
63
|
12.77 |
RAF1 KRAS HRAS EGFR AKT1 |
20 |
Show member pathways
CD27 Pathway
63
CD40 Signaling
63
CMV and MAPK Pathways
63
NF-KappaB Activation by EBV
63
NF-kappaB Activation by Viruses
63
PKR Pathway
63
SUMO Pathway
63
TNFR2 Pathway
63
|
12.77 |
TP53 RAF1 KRAS HRAS EGFR AKT1 |
21 |
Show member pathways
|
12.76 |
TP53 RAF1 KRAS HRAS EGFR CDKN2A |
22 |
Show member pathways
Cytoskeleton remodeling FAK signaling
22
Development Endothelin-1/EDNRA transactivation of EGFR
22
|
12.75 |
RAF1 KRAS HRAS EGFR AKT1 |
23 |
Show member pathways
|
12.71 |
RAF1 KRAS HRAS EGFR AKT1 |
24 |
Show member pathways
|
12.7 |
TP53 RAF1 MYC KRAS HRAS EGFR |
25 |
Show member pathways
Angiopoietin-TIE2 Signaling
63
Development Angiopoietin - Tie2 signaling
22
Development PDGF signaling via STATs and NF-kB
22
Immune response IL-10 signaling pathway
22
|
12.69 |
TP53 MYC KRAS HRAS EGFR AKT1 |
26 |
Show member pathways
Development Prolactin receptor signaling
22
|
12.6 |
RAF1 MYC KRAS HRAS AKT1 |
27 |
Show member pathways
|
12.6 |
TP53 RAF1 KRAS HRAS EGFR AKT1 |
28 |
Show member pathways
|
12.57 |
RAF1 MYC KRAS HRAS EGFR AKT1 |
29 |
Show member pathways
|
12.56 |
TP53 KRAS HRAS EGFR AKT1 |
30 |
Show member pathways
|
12.56 |
TP53 RAF1 MYC KRAS HRAS EGFR |
31 |
Show member pathways
CCKBR-Gastrin Stimulated Signaling
63
Development VEGF-family signaling
22
VEGF Pathway
63
|
12.53 |
RAF1 KRAS HRAS EGFR AKT1 |
32 |
Show member pathways
|
12.52 |
RAF1 MYC KRAS HRAS AKT1 |
33 |
Show member pathways
|
12.52 |
RAF1 KRAS HRAS EGFR AKT1 |
34 |
Show member pathways
Immune response IL-4 signaling pathway
22
Signal transduction AKT signaling
22
|
12.51 |
TP53 RAF1 MYC HRAS AKT1 |
35 |
Show member pathways
Development VEGF signaling and activation
22
|
12.49 |
RAF1 KRAS HRAS AKT1 |
36 |
Show member pathways
Development FGF-family signaling
22
Development Flt3 signaling
22
FGF Pathway
63
|
12.49 |
RAF1 KRAS HRAS AKT1 |
37 |
|
12.46 |
TP53 RAF1 MYC MIR30C1 KRAS HRAS |
38 |
|
12.44 |
TP53 MYC KRAS HRAS CDKN2A AKT1 |
39 |
Show member pathways
FLT3 Signaling
63
IL-3 Pathway
63
Nur77-Induced AICD in Macrophage
63
OSM Pathway
63
|
12.43 |
RAF1 KRAS HRAS AKT1 |
40 |
Show member pathways
Development A1 receptor signaling
22
G-protein signaling G-Protein alpha-q signaling cascades
22
|
12.42 |
RAF1 MYC HRAS AKT1 |
41 |
Show member pathways
Transcription CREB pathway
22
Transcription PPAR Pathway
22
|
12.42 |
RAF1 HRAS EGFR AKT1 |
42 |
Show member pathways
Transcription Androgen Receptor nuclear signaling
22
|
12.42 |
TP53 RAF1 HRAS EGFR AKT1 |
43 |
Show member pathways
|
12.41 |
KRAS HRAS EGFR AKT1 |
44 |
|
12.4 |
RAF1 MYC HRAS AKT1 |
45 |
|
12.4 |
TP53 KRAS HRAS CDKN2A |
46 |
Show member pathways
Development ERBB-family signaling
22
EGF Pathway
63
|
12.4 |
RAF1 MYC KRAS HRAS EGFR AKT1 |
47 |
Show member pathways
Immune response Oncostatin M signaling via MAPK in human cells
22
|
12.39 |
TP53 RAF1 KRAS HRAS EGFR AKT1 |
48 |
Show member pathways
|
12.37 |
TP53 MYC KRAS EGFR AKT1 |
49 |
Show member pathways
|
12.31 |
RAF1 KRAS HRAS AKT1 |
50 |
Show member pathways
|
12.31 |
TP53 RAF1 MYC KRAS HRAS EGFR |